Avricore Health Provides Update on Status of Management Cease Trade Order

Author's Avatar
May 16, 2019
Article's Main Image

Vancouver, May 16, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR) (“Avricore Health” or the “Company”) is providing this update on the status of a management cease trade order granted on May 2, 2019 (the "MCTO") by the British Columbia Securities Commission under National Policy 12-203 – Management Cease Trade Order ("NP 12-203"). On May 2, 2019, the Company announced that, for reasons disclosed in the news release, there would be a delay in the filing of its financial statements and accompanying management’s discussion and analysis for the fiscal year ended December 31, 2018 (the "Annual Filings") beyond the period prescribed under applicable Canadian securities laws (the "Default Announcement").